Interesting results from a pre-clinical study on CBD as an antidepressant, the findings reinforce those of prior research showing that cannabidiol (CBD) has promising therapeutic potential in the treatment of broad-spectrum depression in preclinical and human models:
https://www.eurekalert.org/pub_releases/2018-08/fda-itw083018.php
https://link.springer.com/article/10.1007/s12035-018-1143-4